These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20426761)

  • 1. Recent patents and advances in genomic biomarker discovery for colorectal cancers.
    Quyun C; Ye Z; Lin SC; Lin B
    Recent Pat DNA Gene Seq; 2010 Jun; 4(2):86-93. PubMed ID: 20426761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.
    Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
    Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
    Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.
    Muhammad S; Kaur K; Huang R; Zhang Q; Kaur P; Yazdani HO; Bilal MU; Zheng J; Zheng L; Wang XS
    World J Gastroenterol; 2014 Dec; 20(45):17011-9. PubMed ID: 25493013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
    Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive molecular biomarkers for the detection of colorectal cancer.
    Kim HJ; Yu MH; Kim H; Byun J; Lee C
    BMB Rep; 2008 Oct; 41(10):685-92. PubMed ID: 18959813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Blood and Plasma MicroRNAs as a Non-Invasive Biomarker in Patients with Colorectal Cancer.
    Stefanescu H; Muntean D; Pilut C; Diaconu M; Popescu R; Hutanu D; Moise M; Diana L; Nitu R; Cherecheanu AP; Negoita S; Iovan CV; Ungureanu E; Calu V; Ciuca I
    Clin Lab; 2018 Mar; 64(3):257-262. PubMed ID: 29739108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic markers in colorectal cancer screening: recent advances.
    Singh MP; Rai S; Suyal S; Singh SK; Singh NK; Agarwal A; Srivastava S
    Expert Rev Mol Diagn; 2017 Jul; 17(7):665-685. PubMed ID: 28562109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
    Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
    Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated regulatory mechanisms of miRNAs and targeted genes involved in colorectal cancer.
    Wang J; Yu H; Ye L; Jin L; Yu M; Lv Y
    Int J Clin Exp Pathol; 2015; 8(1):517-29. PubMed ID: 25755742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Biomarkers in Colorectal Cancer.
    Verma M; Kumar V
    Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.
    Hernández R; Sánchez-Jiménez E; Melguizo C; Prados J; Rama AR
    BMB Rep; 2018 Nov; 51(11):563-571. PubMed ID: 30158023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.